Belantamab Mafodotin Combination Therapy
A Phase I/II Study of the Safety, Tolerability and Efficacy of Belantamab Mafodotin (GSK2857916) in Combination With Iberdomide (CC-220)/Dexamethasone Versus Belantamab Mafodotin (GSK2857916)/Dexamethasone in Relapsed Refractory Multiple Myeloma
Filters
Save & Share
Clear Filters
Location
Explore options near your home - or near family and friends.
Diagnosis
Treatment History
Near Add Your Location
Sorting 12 by
Memorial Sloan Kettering Cancer Center
New York, NY
- Not yet accepting
Mary Greeley Medical Center
Ames, IA
- Not yet accepting
All clinical trials have eligibility criteria - or a list of reasons why you may be able or unable to participate in a trial. Answer a few questions to view your personalized results - all in under 60 seconds.
Help me find trialsMcFarland Clinic PC
Ames, IA
- Not yet accepting
McFarland Clinic PC (Boone)
Boone, IA
- Not yet accepting
McFarland Clinic Trinity Cancer Center
Fort Dodge, IA
- Not yet accepting
McFarland Clinic PC (Jefferson)
Jefferson, IA
- Not yet accepting
McFarland Clinic PC (Marshalltown)
Marshalltown, IA
- Not yet accepting
Memorial Sloan Kettering Monmouth
Middletown, NJ
- Not yet accepting
Memorial Sloan Kettering Bergen
Montvale, NJ
- Not yet accepting
Memorial Sloan Kettering Commack
Commack, NY
- Not yet accepting
Real People. Real Support.
Need help connecting with this clinical trial? We're here to help!
Print this trial to share with your doctor.
We can help answer any questions and connect you (or your patient) with the study team.
Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.